New York State Common Retirement Fund Keros Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $76.2 Billion
- Q2 2024
A detailed history of New York State Common Retirement Fund transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,616 shares of KROS stock, worth $712,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,616
Previous 17,122
26.32%
Holding current value
$712,173
Previous $1.13 Million
49.07%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KROS
# of Institutions
157Shares Held
27.1MCall Options Held
28.7KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$99.2 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$90.3 Million0.12% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$86.1 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$71.6 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.45B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...